138 related articles for article (PubMed ID: 11786281)
41. Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
Storch D; Béhé M; Walter MA; Chen J; Powell P; Mikolajczak R; Mäcke HR
J Nucl Med; 2005 Sep; 46(9):1561-9. PubMed ID: 16157541
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
43. Lys and Arg in UBI: a specific site for a stable Tc-99m complex?
Meléndez-Alafort L; Ramírez Fde M; Ferro-Flores G; Arteaga de Murphy C; Pedraza-López M; Hnatowich DJ
Nucl Med Biol; 2003 Aug; 30(6):605-15. PubMed ID: 12900286
[TBL] [Abstract][Full Text] [Related]
44. Preparation and comparative evaluation of
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Banerjee S
J Labelled Comp Radiopharm; 2018 Feb; 61(2):68-76. PubMed ID: 29139598
[TBL] [Abstract][Full Text] [Related]
45. (99m)Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model.
Karczmarczyk U; Markiewicz A; Mikołajczak R; Lisiak E; Bilski M; Pietrzykowski J; Michalik J
Nucl Med Rev Cent East Eur; 2004; 7(2):107-12. PubMed ID: 15968595
[TBL] [Abstract][Full Text] [Related]
46. A novel ternary ligand system for 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands.
Liu S; Edwards DS; Harris AR
Bioconjug Chem; 1998; 9(5):583-95. PubMed ID: 9736492
[TBL] [Abstract][Full Text] [Related]
47. 99mTc-labeled bombesin(7-14)NH2 with favorable properties for SPECT imaging of colon cancer.
Shi J; Jia B; Liu Z; Yang Z; Yu Z; Chen K; Chen X; Liu S; Wang F
Bioconjug Chem; 2008 Jun; 19(6):1170-8. PubMed ID: 18491928
[TBL] [Abstract][Full Text] [Related]
48. [
Mazaheri Tehrani M; Erfani M; Amirmozafari N
Chem Biol Drug Des; 2021 Apr; 97(4):904-913. PubMed ID: 33326679
[TBL] [Abstract][Full Text] [Related]
49. New and versatile ternary ligand system for technetium radiopharmaceuticals: water soluble phosphines and tricine as coligands in labeling a hydrazinonicotinamide-modified cyclic glycoprotein IIb/IIIa receptor antagonist with 99mTc.
Edwards DS; Liu S; Barrett JA; Harris AR; Looby RJ; Ziegler MC; Heminway SJ; Carroll TR
Bioconjug Chem; 1997; 8(2):146-54. PubMed ID: 9095354
[TBL] [Abstract][Full Text] [Related]
50. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging.
Jiang Y; Fang S; Feng J; Ruan Q; Zhang J
Mol Pharm; 2023 Jan; 20(1):630-640. PubMed ID: 36398935
[TBL] [Abstract][Full Text] [Related]
52. Comparative assessment of a
Torabizadeh SA; Abedi SM; Noaparast Z; Hosseinimehr SJ
Bioorg Med Chem; 2017 May; 25(9):2583-2592. PubMed ID: 28351606
[TBL] [Abstract][Full Text] [Related]
53. Breast tumor targeting with (99m)Tc-HYNIC-PR81 complex as a new biologic radiopharmaceutical.
Salouti M; Rajabi H; Babaei MH; Rasaee MJ
Nucl Med Biol; 2008 Oct; 35(7):763-8. PubMed ID: 18848661
[TBL] [Abstract][Full Text] [Related]
54. 99mTc-HYNIC-Gastrin Peptides: Assisted Coordination of 99mTc by Amino Acid Side Chains Results in Improved Performance Both In Vitro and In Vivo.
King R; Surfraz MB; Finucane C; Biagini SC; Blower PJ; Mather SJ
J Nucl Med; 2009 Apr; 50(4):591-8. PubMed ID: 19289435
[TBL] [Abstract][Full Text] [Related]
55. A single-step kit formulation for the (99m)Tc-labeling of HYNIC-Duramycin.
Zhao M; Li Z
Nucl Med Biol; 2012 Oct; 39(7):1006-11. PubMed ID: 22858374
[TBL] [Abstract][Full Text] [Related]
56. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
57. Labeling polyamidoamine (PAMAM) dendrimers with technetium-99m via hydrazinonicotinamide (HYNIC).
Kovacs L; Tassano M; Cabrera M; Fernández M; Porcal W; Anjos RM; Cabral P
Curr Radiopharm; 2014; 7(2):115-22. PubMed ID: 25175622
[TBL] [Abstract][Full Text] [Related]
58. Tricine co-ligand improved the efficacy of
Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and Biological Evaluation of Cyclic [
Rezaeianpour S; Bozorgi AH; Moghimi A; Almasi A; Balalaie S; Ramezanpour S; Nasoohi S; Mazidi SM; Geramifar P; Bitarafan-Rajabi A; Shahhosseini S
Mol Imaging Biol; 2017 Apr; 19(2):256-264. PubMed ID: 27632423
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]